# In the Mix: 10 More Articles — April 08, 2026

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/delta-8-gummies-for-sleep-2026-guide/
> **Published:** 2026-10-21T15:00:00-04:00 | **Last Modified / Clinically Audited:** 2026-09-17T15:59:45-04:00
> **Clinical Summary:** Delta 8 gummies for sleep 2026 are gaining attention for their potential benefits via the endocannabinoid system. This article reviews dosing information and br

---

In the Mix — Last 24 HoursApril 08, 2026. 10 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.

#25

[Here’s what psychedelics actually do to the brain – AOL.com](https://www.aol.com/articles/heres-psychedelics-actually-brain-150000931.html?utm_source=join1440&utm_medium=email&utm_placement=newsletter&user_id=66c4bec35d78644b3aa16101)

Article discusses psychedelic effects on the brain via the IMPACT study and raises questions about cannabis versus specific cannabinoid compounds, potentially relevant to clinicians studying cannabinoid mechanisms.

[Read more →](https://www.aol.com/articles/heres-psychedelics-actually-brain-150000931.html?utm_source=join1440&utm_medium=email&utm_placement=newsletter&user_id=66c4bec35d78644b3aa16101)

#15
[WEED, Inc. (BUDZ) posts $1.37M loss and flags going concern risk](https://www.stocktitan.net/sec-filings/BUDZ/10-k-weed-inc-files-annual-report-d95583292ed9.html)

WEED, Inc.’s financial struggles and going-concern warnings highlight industry-wide viability challenges that clinicians may monitor for potential impacts on [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) accessibility and product availability.

[Read more →](https://www.stocktitan.net/sec-filings/BUDZ/10-k-weed-inc-files-annual-report-d95583292ed9.html)

#15
[Delta 8 Gummies For Sleep In 2026: A Craft Beer Lover’s Guide (Benefits, Brands & Dosage)](https://breweriesinpa.com/delta-8-gummies-for-sleep-in-2026-a-craft-beer-lovers-guide-benefits-brands-dosage/)

Summary

This article reviews Delta 8 gummies for sleep, including purported mechanisms of action via the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/), onset timing, dosing information, and brand recommendations.

[Read more →](https://breweriesinpa.com/delta-8-gummies-for-sleep-in-2026-a-craft-beer-lovers-guide-benefits-brands-dosage/)

#15
[Opening day of Somerset County’s first cannabis dispensary | Latest News | wboc.com](https://www.wboc.com/news/opening-day-of-somerset-countys-first-cannabis-dispensary/video_b25a2a0c-d81a-5283-b134-0bb50884a749.html)

Somerset County’s first cannabis dispensary, Happi Daze, opened this week, representing local market expansion that clinicians may monitor for patient access and referral patterns in their region.

[Read more →](https://www.wboc.com/news/opening-day-of-somerset-countys-first-cannabis-dispensary/video_b25a2a0c-d81a-5283-b134-0bb50884a749.html)

#15
[Protest held over closure of N.B. cannabis dispensary – YouTube](https://www.youtube.com/watch?v=ifP25QXNI_0)

A cannabis dispensary closure in Moncton prompted a public protest, illustrating community engagement with cannabis retail regulations and access issues.

[Read more →](https://www.youtube.com/watch?v=ifP25QXNI_0)

#15
[Tree Huggers Orange Sour Craft Cannabis Soda, Orange Sour – EWG’s Food Scores](https://www.ewg.org/foodscores/products/810106601120-TreeHuggersOrangeSourCraftCannabisSodaOrangeSour/)

This article reviews a cannabis-infused beverage product through a nutritional/ingredient database, potentially of interest to clinicians counseling patients on edible product composition and formulation.

[Read more →](https://www.ewg.org/foodscores/products/810106601120-TreeHuggersOrangeSourCraftCannabisSodaOrangeSour/)

#15
[Largest-ever Psychedelics Study Could Advance Use in Treating Mental Health Disorders](https://www.cannabisequipmentnews.com/news/news/22964370/largestever-psychedelics-study-could-advance-use-in-treating-mental-health-disorders)

This article mentions a large psychedelics study alongside cannabis industry news, potentially relevant to clinicians tracking therapeutic [drug development](https://cedclinic.com/hydrogen-sulfide-releasing-nsaid-derivative/) and cannabis market consolidation trends.

[Read more →](https://www.cannabisequipmentnews.com/news/news/22964370/largestever-psychedelics-study-could-advance-use-in-treating-mental-health-disorders)

#15
[Police Are Calling It One Of The Biggest Marijuana Busts Ever. What’s it Worth? Over A … – Facebook](https://www.facebook.com/7NewsBelize/posts/police-are-calling-it-one-of-the-biggest-marijuana-busts-ever-whats-it-worth-ove/1353830696771496/)

This article reports on a major marijuana seizure in Belize, potentially offering insights into regional drug trafficking patterns and supply chain dynamics relevant to cannabis market understanding.

[Read more →](https://www.facebook.com/7NewsBelize/posts/police-are-calling-it-one-of-the-biggest-marijuana-busts-ever-whats-it-worth-ove/1353830696771496/)

#15
[Before legalization, Springfield’s weed stories lived in schoolyards, pool halls and creek bottoms](https://www.ozarksfirst.com/news/springfield-mo-marijuana-scare/)

This article examines Springfield’s historical marijuana narratives from 1934 onward, documenting evolving public perception—potentially relevant for understanding how social attitudes shaped clinical and legal frameworks.

[Read more →](https://www.ozarksfirst.com/news/springfield-mo-marijuana-scare/)

#5
[The biggest misconception about Weedstock is that people come for the marijuana … – Instagram](https://www.instagram.com/p/DW49hRTE7dV/)

Summary

Weedstock event attendees prioritize music, art, and camping experiences over cannabis products, offering insights into cannabis consumer demographics and lifestyle associations relevant to understanding patient populations.

[Read more →](https://www.instagram.com/p/DW49hRTE7dV/)

Digest-Level Clinical Commentary

 Dr. Caplan’s Take
 These digest items reflect a fragmented landscape where [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) remains overshadowed by commercial interests, regulatory transitions, and consumer product marketing rather than rigorous clinical evidence. The notable absence of peer-reviewed efficacy data, controlled trials beyond the mentioned IMPACT study, or standardized dosing protocols suggests that clinical cannabis practice continues to operate in an evidence gap, particularly for conditions like sleep where Delta 8 products proliferate without robust safety profiles in older populations. As a physician, I’m observing that public discourse and market expansion are outpacing our ability to generate the quality evidence needed to guide patient care responsibly, which demands that we remain cautious about endorsing specific compounds or products without stronger clinical validation.

 Clinical Perspective

These items reflect an evolving cannabis landscape characterized by commercial expansion, product diversification beyond traditional flower, and increased [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) into cannabinoids and related compounds for therapeutic applications. The digest demonstrates simultaneous growth in retail infrastructure and regulatory activity, alongside emerging consumer interest in specific cannabinoid formulations marketed for particular health outcomes such as sleep. The clinical relevance centers on the need for rigorous evidence generation to distinguish between marketing claims and actual therapeutic efficacy as the market continues to develop.

LegalizationBusinessRetailPsychedelicsProducts

💬 Join the Conversation

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/ask-dr-caplan/)

## FAQ

This News item was assembled from structured source metadata and pipeline scoring.

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+In+the+Mix+%E2%80%94+April+08%2C+2026+%40drcaplan&url=)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+In+the+Mix+%E2%80%94+April+08%2C+2026+--+via+%40drcaplan.bsky.social+)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

 Related Articles

- [Here’s what psychedelics actually do to the brain – AOL.com](https://cedclinic.com/here-s-what-psychedelics-actually-do-to-the-brain-aol-com/)

- [Brain scans reveal how a woman voluntarily enters a psychedelic-like trance without drugs](https://cedclinic.com/brain-scans-reveal-how-a-woman-voluntarily-enters-a-psychedelic-like-trance-with/)

- [Psychedelic therapy shows no benefit over antidepressants: Study](https://cedclinic.com/psychedelic-therapy-shows-no-benefit-over-antidepressants-study/)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[In the Mix: 9 More Articles — April 09, 2026](https://cedclinic.com/in-the-mix-9-more-articles-april-09-2026/)

Continue exploring recent cannabis and psychedelics articles with clinical relevance updates from April 09, 2026.

[Read More](https://cedclinic.com/in-the-mix-9-more-articles-april-09-2026/)

[In the Mix: 11 More Articles — March 24, 2026](https://cedclinic.com/in-the-mix-11-more-articles-march-24-2026/)

Review a comprehensive digest of cannabis and psychedelic research articles from March 24, 2026.

[Explore Articles](https://cedclinic.com/in-the-mix-11-more-articles-march-24-2026/)

[In the Mix: 4 More Articles — April 23, 2026](https://cedclinic.com/in-the-mix-4-more-articles-april-23-2026/)

Stay updated with the latest clinical and market developments in cannabis from April 23, 2026.

[Discover More](https://cedclinic.com/in-the-mix-4-more-articles-april-23-2026/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
